EPCT-02. COMPARISON OF TARGETED AGENTS RECOMMENDED BY THE CNS-TAP TOOL TO THOSE SELECTED BY A TUMOR BOARD IN A MOLECULARLY-DRIVEN DIPG CLINICAL TRIAL

Recently, sequencing of diffuse intrinsic pontine glioma (DIPG) biopsy specimens has revealed genomic heterogeneity of these tumors, fueling an interest in individualized, targeted treatment options. The Pacific Pediatric Neuro-Oncology Consortium recently completed enrollment onto a feasibility stu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Roberts, Holly, Ravi, Karthik, Marini, Bernard, Kline, Cassie, Mueller, Sabine, Koschmann, Carl, Franson, Andrea
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Translational/Early Phase Clinical Trials
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168218/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noab090.188
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items